Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 18, 2018 9:12am EDT

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test

May 08, 2018 4:05pm EDT

OPKO Health Reports First Quarter 2018 Financial Results

May 02, 2018 10:00am EDT

OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018

May 01, 2018 8:55am EDT

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories

Apr 27, 2018 4:30pm EDT

OPKO Health to Remain on the Tel Aviv Stock Exchange

Mar 23, 2018 8:00am EDT

OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes

Mar 16, 2018 8:00am EDT

OPKO Health Announces Landmark Study Showing 4KscoreĀ® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology

Mar 01, 2018 4:05pm EST

OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

Feb 26, 2018 4:05pm EST

OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018

Jan 26, 2018 8:00am EST

OPKO Health Announces Leadership Changes at BioReference Laboratories

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap